Earnings Feed
Start Free
PRAECIS PHARMACEUTICALS INC·4

Feb 10, 11:07 AM ET

GARNICK MARC B 4

4 · PRAECIS PHARMACEUTICALS INC · Filed Feb 10, 2004

Insider Transaction Report

Form 4
Period: 2004-02-09
PRAECIS PHARMACEUTICALS INCPRCS
GARNICK MARC B
EVP and Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock, par value $.01 per share

    2004-02-09$0.27/sh+52,499$14,175→ 460,221 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2004-02-09−52,499→ 0 total
    Exercise: $0.27From: 2004-02-09Exp: 2006-07-11→ Common Stock, par value $.01 per share (52,499 underlying)
Holdings

  • Common Stock, par value $.01 per share

    (indirect: By Trust)
    36,000

  • Common Stock, par value $.01 per share

    (indirect: By Trust)
    25,270
Footnotes (1)
  • [F1]The term of the option is ten years from the date of grant.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT